Assessment of Liver Fatty Acid Binding Protein
(L-FABP) as a Diagnostic Marker in
Non-Alcoholic Fatty Liver Diseaseng/sensitivity, specificity, PPV, NPV and accuracy were 90%,
How to cite this paper: Abdulaziz, B.A.,
Abdu, S.A., Amin, A.M., El Menyawi,
A.K.A.H., Ahmed, A., Khalil, M.A. and
Halim, W.A.A. (2019) Assessment of Liver
Fatty Acid Binding Protein (L-FABP) as a
Diagnostic Marker in Non-Alcoholic Fatty
Liver Disease. Open Journal of Gastroenterology, 9, 113-124.
https://doi.org/10.4236/ojgas.2019.96014
Received: May 9, 2019
Accepted: June 25, 2019
Published: June 28, 2019
Copyright © 2019 by author(s) and
Scientific Research Publishing Inc.
This work is licensed under the Creative
Commons Attribution International
License (CC BY 4.0).
http://creativecommons.org/licenses/by/4.0/
Open Access
B. A. Abdulaziz et al.
DOI: 10.4236/ojgas.2019.96014 114 Open Journal of Gastroenterology
90%, 95.4%, 95.4%, 88.9% with AUC was 0.950. Conclusion: Serum L-FABP
could be used as a new diagnostic biomarker for detecting NAFLD. |
